{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:52:02Z","timestamp":1789451522718,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.clineuro.2004.12.002","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T08:51:20Z","timestamp":1105606280000},"page":"355-360","source":"Crossref","is-referenced-by-count":59,"title":["Cerebrospinal fluid biomarkers in Creutzfeldt\u2013Jakob disease"],"prefix":"10.1016","volume":"107","author":[{"given":"B.","family":"Van Everbroeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2004.12.002_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1750-3639.1998.tb00171.x","article-title":"The prion diseases","volume":"8","author":"Prusiner","year":"1998","journal-title":"Brain Pathol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib2","first-page":"81","article-title":"The many faces of human prion diseases in Belgium and the world","volume":"101","author":"Van Everbroeck","year":"2001","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.clineuro.2004.12.002_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: classification and characterisation","volume":"66","author":"Gambetti","year":"2003","journal-title":"Br Med Bull"},{"key":"10.1016\/j.clineuro.2004.12.002_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.161.3839.388","article-title":"Creutzfeldt\u2013Jakob disease (spongiform encephalopathy): transmission to the chimpanzee","volume":"161","author":"Gibbs","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.clineuro.2004.12.002_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.45.3.235","article-title":"Evidence for case-to-case transmission of Creutzfeldt\u2013Jakob disease","volume":"45","author":"Will","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2004.12.002_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-510X(98)00226-3","article-title":"Creutzfeldt\u2013Jakob disease via dural and corneal transplants","volume":"160","author":"Lang","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clineuro.2004.12.002_bib7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt\u2013Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2004.12.002_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2004.12.002_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2004.12.002_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1023\/A:1007581313067","article-title":"A retrospective study of Creutzfeldt\u2013Jakob disease in Belgium","volume":"15","author":"Pals","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00415-004-0311-9","article-title":"Differential diagnosis of 201 possible Creutzfeldt\u2013Jakob disease patients","volume":"251","author":"Van Everbroeck","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000115132","article-title":"Brain and CSF proteins in Creutzfeldt\u2013Jakob disease","volume":"19","author":"Olsson","year":"1980","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.55.4.514","article-title":"14-3-3 testing in diagnosing Creutzfeldt\u2013Jakob disease: a prospective study in 112 patients","volume":"55","author":"Lemstra","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib14","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.clineuro.2004.12.002_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0968-0004(92)90339-B","article-title":"14-3-3 Proteins: a highly conserved, widespread family of eukaryotic proteins","volume":"17","author":"Aitken","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.clineuro.2004.12.002_bib16","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1073\/pnas.85.19.7084","article-title":"Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases","volume":"85","author":"Ichimura","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clineuro.2004.12.002_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-5793(93)81640-L","article-title":"Antibodies against the major brain isoforms of 14-3-3 protein: an antibody specific for the N-acetylated amino-terminus of a protein","volume":"336","author":"Martin","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clineuro.2004.12.002_bib18","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1074\/jbc.270.11.5706","article-title":"14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF","volume":"270","author":"Aitken","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clineuro.2004.12.002_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1471-4159.1982.tb07928.x","article-title":"Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders","volume":"38","author":"Boston","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.clineuro.2004.12.002_bib20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1046\/j.1471-4159.1999.0732485.x","article-title":"Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"73","author":"Wiltfang","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.clineuro.2004.12.002_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2004.12.002_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0378-4347(00)83877-3","article-title":"Cerebrospinal fluid protein analysis in diseases of the nervous system","volume":"429","author":"Harrington","year":"1988","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clineuro.2004.12.002_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198607313150502","article-title":"Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"315","author":"Harrington","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2004.12.002_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000017095","article-title":"14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"10","author":"Beaudry","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.clineuro.2004.12.002_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","article-title":"Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt\u2013Jakob disease","volume":"70","author":"Green","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2004.12.002_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A prospective study of CSF markers in 250 patients with possible Creutzfeldt\u2013Jakob disease","volume":"74","author":"Van Everbroeck","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2004.12.002_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(03)00083-2","article-title":"Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis","volume":"212","author":"Satoh","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clineuro.2004.12.002_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.56.7.986","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt\u2013Jakob disease\u2014Reply","volume":"56","author":"Chapman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000008054","article-title":"The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture","volume":"41","author":"Satoh","year":"1999","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.54.7.1539","article-title":"Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy","volume":"54","author":"Echebarria","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A","article-title":"An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt\u2013Jakob disease patients","volume":"48","author":"Kenney","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib34","first-page":"1291","article-title":"A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt\u2013Jakob patients","volume":"46","author":"Leuck","year":"2000","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(01)01619-6","article-title":"Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt\u2013Jakob patients by a highly sensitive capture assay","volume":"301","author":"Peoch","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clineuro.2004.12.002_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(02)00172-6","article-title":"14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt\u2013Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein","volume":"324","author":"Green","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clineuro.2004.12.002_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1034\/j.1600-0404.2000.102006385.x","article-title":"Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt\u2013Jakob disease","volume":"102","author":"Kohira","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2004.12.002_bib38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(95)90118-3","article-title":"Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt\u2013Jakob disease","volume":"345","author":"Zerr","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2004.12.002_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0304-3940(98)00992-6","article-title":"Increase of neuron-specific enolase in patients with Creutzfeldt\u2013Jakob disease","volume":"261","author":"Kropp","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clineuro.2004.12.002_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004150050145","article-title":"S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"244","author":"Otto","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clineuro.2004.12.002_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt\u2013Jakob disease","volume":"58","author":"Otto","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","article-title":"Decreased beta-amyloid1\u201342 in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"54","author":"Otto","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JAD-1999-1606","article-title":"Decreased levels of amyloid-beta 1\u201342 in cerebrospinal fluid of Creutzfeldt\u2013Jakob disease patients","volume":"1","author":"Van Everbroeck","year":"1999","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.clineuro.2004.12.002_bib45","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1073\/pnas.97.10.5468","article-title":"Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets","volume":"97","author":"Bieschke","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clineuro.2004.12.002_bib46","doi-asserted-by":"crossref","first-page":"31479","DOI":"10.1074\/jbc.C100278200","article-title":"A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases","volume":"276","author":"Shaked","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clineuro.2004.12.002_bib47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(03)12632-3","article-title":"Deaths from variant Creutzfeldt\u2013Jakob disease in the UK","volume":"361","author":"Andrews","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2004.12.002_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W","article-title":"Diagnosis of new variant Creutzfeldt\u2013Jakob disease","volume":"47","author":"Will","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib49","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.324.7352.1479","article-title":"First hundred cases of variant Creutzfeldt\u2013Jakob disease: retrospective case note review of early psychiatric andneurological features","volume":"324","author":"Spencer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.clineuro.2004.12.002_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(97)07472-2","article-title":"New variant Creutzfeldt\u2013Jakob disease: neurological features and diagnostic tests","volume":"350","author":"Zeidler","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2004.12.002_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2004.12.002_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410350404","article-title":"Human prion diseases","volume":"35","author":"Prusiner","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00143125","article-title":"Creutzfeldt\u2013Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families","volume":"7","author":"Goldfarb","year":"1991","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00162311","article-title":"Epidemiologic implications of Creutzfeldt\u2013Jakob disease in a 19-year-old girl","volume":"1","author":"Brown","year":"1985","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib55","first-page":"241","article-title":"Human prion diseases","volume":"3","author":"Collinge","year":"1994","journal-title":"Baillieres Clin Neurol"},{"key":"10.1016\/j.clineuro.2004.12.002_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.49.2.593","article-title":"Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt\u2013Jakob disease","volume":"49","author":"Rosenmann","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.002_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1054\/jocn.1999.0193","article-title":"Creutzfeldt\u2013Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid","volume":"7","author":"Collins","year":"2000","journal-title":"J Clin Neurosci"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846704002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846704002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T03:25:42Z","timestamp":1548818742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846704002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0303846704002057"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2004.12.002","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}